| 摘要: |
| 目的：探讨复方甘草酸苷在儿童紫癜性肾炎中的应用价值。方法：选择2015-2017年我院儿科收治的紫癜性肾炎患儿90例，按随机数表法分为对照组和观察组各45例。对照组采用常规疗，即静脉给予维生素C和钙剂，同时给予激素、抗过敏、抗凝、雷公藤多苷片等治疗；观察组患儿在对照组基础上加用复方甘草酸苷辅助治疗，3~5岁80 mg，6~14岁120 mg，口服，1次/天。30 d为1个疗程，两组患儿均治疗2个疗程。观察两组患儿临床症状缓解情况，比较治疗前后炎症因子和免疫功能的变化。结果：观察组患儿紫癜消失时间、肾损害恢复时间、关节疼痛消失时间及水肿消失时间均少于对照组（P均<0.05）。治疗前两组患儿游离细胞间黏附分子-1（sICAM-1）、基质金属蛋白酶-9（MMP-9）、T淋巴细胞亚群水平比较，差异均无统计学意义（P均>0.05）；治疗后两组患儿sICAM-1、MMP-9和CD8+水平均降低，且观察组均低于对照组（P均<0.05），CD3+、CD4+和CD4+/CD8+水平均升高，且观察组均高于对照组（P均<0.05）。结论：复方甘草酸苷辅助治疗紫癜性肾炎患儿，可显著缓解炎症应激反应和提高免疫功能，改善临床症状，值得临床推广应用。 |
| 关键词: 复方甘草酸苷 紫癜性肾炎 儿童 炎症因子 免疫功能 |
| DOI：doi:10.13407/ j.cnki.jpp.1672-108X.2019.05.010 |
|
| 基金项目: |
|
| Compound Glycyrrhisim in the Treatment of Children with Henoch-Schönlein Purpura Nephritis |
| Lu Xincui, Sun Xingzhen, Ma Li |
| (The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Jiangsu Huai’an 223300, China) |
| Abstract: |
| Objective: To investigate the application value of compound glycyrrhisim in the treatment of children with Henoch-Schönlein purpura nephritis. Methods: Totally 90 patients with Henoch-Schönlein purpura nephritis admitted into pediatrics of our hospital from 2015 to 2017 were selected to be divided into the control group and the observation group via the random number table, with 45 cases in each group. The control group was treated with conventional regimen, namely, intravenous vitamin C and calcium, and hormone, anti-allergic, anticoagulant and Tripterygium glycosides tablets. The observation group additionally received compound glycyrrhizin on the basis of the control group, 80 mg at the age of 3 to 5 years and 120 mg at the age of 6 to 14 years, orally, once a day. A total of 30 d was a course of treatment, and both groups were treated for 2 courses. The clinical symptoms of two groups were observed, the changes of levels of serum inflammatory factors and immune function were compared before and after treatment. Results: The disappearance time of Henoch-Schönlein purpura, the recovery time of renal damage, the disappearance time of joint pain and edema in the observation group were less than those in the control group (P<0.05). There were no significant differences in the levels of free intercellular celladhesionmolecles-1 (sICAM-1), matrix metalloproteinase-9 (MMP-9) and T lymphocyte subsets between two groups before treatment (P>0.05). After treatment, the levels of sICAM-1, MMP-9 and CD8+ were decreased in both groups, and the observation group was lower than the control group (P<0.05); the levels of CD3+, CD4+ and CD4+/CD8+ were elevated, and the observation group was higher than the control group (P<0.05). Conclusion: Compound glycyrrhizin supplementation in children with Henoch-Schönlein purpura nephritis can significantly alleviate the inflammatory stress response, promote the immune function and improve the clinical symptoms, which is worthy of clinical application. |
| Key words: compound glycyrrhisim Henoch-Schönlein purpura nephritis children inflammation factors immune function |
